Aspire Biopharma dismisses auditor Turner Stone, taps CBIZ as replacement
The company said Turner Stone’s audit report for 2025 included a going-concern paragraph. It said CBIZ CPAs will serve as auditor for fiscal 2026, effective immediately.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.